Neuraly raises $36M series A to develop microglia-targeted PD candidate

Neurodegeneration company Neuraly Inc. (Germantown, Md.) launched July 18 with a tranched $36 million series A round led by new investor D&D Pharmatech (Gyeonggi-do, Korea).

Read the full 256 word article

User Sign In